Work

Asociación entre el uso prolongado de metformina y deficiencia de vitamina B12 en pacientes diabéticos tipo 2

Year: 2024
Type: article
Study design: Observational Study
Abstract: Introduction: Since its introduction in the mid-1950s in Europe and in 1995 in the United States, metformin is considered the most frequently prescribed medication for the treatment of Type 2 Diabetes Mellitus (Dm2). Objective: To establish the association between prolonged use of metformin and serum vitamin B12 deficiency in patients with type 2 Diabetes Mellitus in the municipality of Soledad-Atlántico. Materials and methods: Analytical, cross-sectional study. The population corresponds to patients diagnosed with Type 2 Diabetes Mellitus treated in 2017 at the IPS Salud Social of the municipality of Soledad- Atlántico. A sample of 84 patients who received treatment lasting more than 3 years, either with metformin (n = 34) or with insulin (n = 44) was selected. Results: The one-way ANOVA analysis of the VitB12 means for both treatment groups shows a decrease in the serum VitB12 average of 36.85 pg. /ml in the metformin-treated group relative to the insulin-treated group. Despite the differences observed, they did not turn out to be statistically significant (p = 0.236). Conclusion: The observed effect of metformin on serum levels of VitB12 is dose-dependent, however, this association was not statistically significant. Additionally, the presence of VitB12 deficiency or megaloblastic anemia associated with the use of metformin was not reported in this study
Language: Spanish
Field: Nursing
Open Access status: diamond
OpenAlex ID: W7220279690
FWCI:
Cites: 15
Cited by:
Related to: 10